Immucell (ICCC) Revenue (2016 - 2025)
Historic Revenue for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $5.5 million.
- Immucell's Revenue fell 840.8% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year increase of 4402.63%. This contributed to the annual value of $26.5 million for FY2024, which is 5163.5% up from last year.
- Per Immucell's latest filing, its Revenue stood at $5.5 million for Q3 2025, which was down 840.8% from $6.4 million recorded in Q2 2025.
- In the past 5 years, Immucell's Revenue registered a high of $8.1 million during Q1 2025, and its lowest value of $3.4 million during Q1 2023.
- Over the past 5 years, Immucell's median Revenue value was $5.4 million (recorded in 2021), while the average stood at $5.4 million.
- Per our database at Business Quant, Immucell's Revenue crashed by 4255.49% in 2023 and then skyrocketed by 11057.65% in 2024.
- Over the past 5 years, Immucell's Revenue (Quarter) stood at $5.4 million in 2021, then fell by 28.16% to $3.9 million in 2022, then soared by 37.99% to $5.4 million in 2023, then skyrocketed by 43.63% to $7.8 million in 2024, then fell by 28.96% to $5.5 million in 2025.
- Its Revenue was $5.5 million in Q3 2025, compared to $6.4 million in Q2 2025 and $8.1 million in Q1 2025.